By comparing the proportion and function of ILC2s infiltrating two different types of lung cancer (a primary tumor producing high IL-33 and a metastatic tumor producing low IL-33), ILC2s were reduced in metastatic- in comparison to primary tumor. This evidence concerns the gene IL33 and metastatic neoplasm.